Apotheek Lamoot SA
19.1 FTEApotheek Lamoot reported total assets of €4.63m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026), with 19.1 full-time equivalents.
The score of Apotheek Lamoot shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +266 % Total assets +20 % Headcount (avg FTE) +36 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Lamoot's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Apotheek Lamoot's financial analysis
- Solvency32.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Lamoot
Apotheek Lamoot's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0430.019.212
- VAT number
- BE0430019212
- Peppol
- Registered · 0208:0430019212 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 17 Dec 1986
- Registered office
- 8908 Ypres
- Size
- Small · 19.1 FTE
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Lamoot (SA) has been based in Ypres since 1986, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 392,465 € and equity of €1.52m; its revenue is not published. With 19.1 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 32.8%, below the median of its sector (44.2%).
Companies similar to Apotheek Lamoot
Companies in the same business, of comparable size and area, outside its group.
- Elbaro Retail sale of pharmaceutical products Merelbeke-Melle · balance sheet €2.78m
- Pharmacie Anselme Retail sale of pharmaceutical products Antoing · balance sheet €4.76m
- Imbefrance Retail sale of pharmaceutical products Halle · balance sheet €5.11m
- Alpaga MDB Retail sale of pharmaceutical products Kontich · balance sheet €5.32m
- Hainapharma Retail sale of pharmaceutical products Aiseau-Presles · balance sheet €4.03m
- Apophar Retail sale of pharmaceutical products Ixelles · balance sheet €5.33m
- Dansaert Retail sale of pharmaceutical products Brussels · balance sheet €3.93m
- Patrimanne Retail sale of pharmaceutical products Stekene · balance sheet €3.82m
Frequently asked questions about Apotheek Lamoot
What is the revenue of Apotheek Lamoot?
Apotheek Lamoot files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Lamoot?
In Belgium, the VAT number is the company number prefixed with BE: BE0430019212 for Apotheek Lamoot, if the company is VAT-registered. Its company number (CBE) is 0430.019.212.
Where is the registered office of Apotheek Lamoot?
According to the CBE register, the registered office of Apotheek Lamoot is in 8908 Ypres.
What is the equity of Apotheek Lamoot?
At the close of the 2025 financial year, the equity of Apotheek Lamoot amounts to 1,517,600 €, a solvency of 32.8% of total assets.
How many people work at Apotheek Lamoot?
19.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Apotheek Lamoot?
The register lists 5 active mandates at Apotheek Lamoot. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Lamoot
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →